These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33953961)

  • 1. Improving therapeutic potential of non-viral minimized DNA vectors.
    Arévalo-Soliz LM; Hardee CL; Fogg JM; Corman NR; Noorbakhsh C; Zechiedrich L
    Cell Gene Ther Insights; 2020 Nov; 6(10):1489-1505. PubMed ID: 33953961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions.
    Weber T
    Front Immunol; 2021; 12():658399. PubMed ID: 33815421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Non-Viral DNA Vectors for Gene Therapy.
    Hardee CL; Arévalo-Soliz LM; Hornstein BD; Zechiedrich L
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for primary myopathies: literature review and prospects.
    Querin G; Colella M
    Arch Pediatr; 2023 Nov; 30(8S1):8S18-8S23. PubMed ID: 38043978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
    Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
    Elife; 2021 Oct; 10():. PubMed ID: 34664552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.
    Kwon I; Schaffer DV
    Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine Learning.
    Becker J; Fakhiri J; Grimm D
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.
    Satkunanathan S; Wheeler J; Thorpe R; Zhao Y
    Hum Gene Ther; 2014 Nov; 25(11):929-41. PubMed ID: 25072415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer gene therapy goes viral: viral vector platforms come of age.
    Bezeljak U
    Radiol Oncol; 2022 Feb; 56(1):1-13. PubMed ID: 35148469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.
    Lee CS; Bishop ES; Zhang R; Yu X; Farina EM; Yan S; Zhao C; Zheng Z; Shu Y; Wu X; Lei J; Li Y; Zhang W; Yang C; Wu K; Wu Y; Ho S; Athiviraham A; Lee MJ; Wolf JM; Reid RR; He TC
    Genes Dis; 2017 Jun; 4(2):43-63. PubMed ID: 28944281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases.
    Jiao L; Sun Z; Sun Z; Liu J; Deng G; Wang X
    Front Bioeng Biotechnol; 2024; 12():1349077. PubMed ID: 38303912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy.
    Wagner HJ; Weber W; Fussenegger M
    Adv Sci (Weinh); 2021 May; 8(9):2004018. PubMed ID: 33977059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
    Walther W; Stein U
    Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial.
    Shieh PB; Kuntz NL; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Servais L; Smith BK; Muntoni F; Blaschek A; Foley AR; Saade DN; Neuhaus S; Alfano LN; Beggs AH; Buj-Bello A; Childers MK; Duong T; Graham RJ; Jain M; Coats J; MacBean V; James ES; Lee J; Mavilio F; Miller W; Varfaj F; Murtagh M; Han C; Noursalehi M; Lawlor MW; Prasad S; Rico S
    Lancet Neurol; 2023 Dec; 22(12):1125-1139. PubMed ID: 37977713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of non-viral gene therapy for CNS disorders.
    Jayant RD; Sosa D; Kaushik A; Atluri V; Vashist A; Tomitaka A; Nair M
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1433-45. PubMed ID: 27249310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector.
    Gonzalez-Fernandez T; Sathy BN; Hobbs C; Cunniffe GM; McCarthy HO; Dunne NJ; Nicolosi V; O'Brien FJ; Kelly DJ
    Acta Biomater; 2017 Jun; 55():226-238. PubMed ID: 28363788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the use of adeno-associated viral vectors for gene therapy.
    Büning H; Braun-Falco M; Hallek M
    Cells Tissues Organs; 2004; 177(3):139-50. PubMed ID: 15388988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Gene Therapy Delivery Systems for Intervertebral Disc Degeneration.
    Chen S; Luo M; Kou H; Shang G; Ji Y; Liu H
    Curr Pharm Biotechnol; 2020; 21(3):194-205. PubMed ID: 31749423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA.
    Tolmachov OE
    Med Hypotheses; 2010 Apr; 74(4):702-4. PubMed ID: 19914006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.